Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...
Saved in:
Main Authors: | Fatemeh Khatami, Mandana Hasanzad |
---|---|
Format: | article |
Language: | EN |
Published: |
Urology Research Center
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
by: Amr Fawzi, et al.
Published: (2017) -
Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
by: D Gnyawali, et al.
Published: (2016) -
Biomarkers for Prostate Cancer Diagnosis from Genetic Perspectives
by: Fatemeh Khatami, et al.
Published: (2020) -
Does MOSES pulse modulation reduce short-term catheter reinsertion following holmium laser enucleation of the prostate?
by: Dane E. Klett, et al.
Published: (2021) -
Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation system
by: Dongu Lee, et al.
Published: (2021)